Ultragenyx PharmaceuticalStock Price and Value Analysis

Should you buy Ultragenyx Pharmaceutical stock? (NasdaqGS:RARE). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is not making money.
  • This company is less known than others.
  • This company pays no dividend.

Inside the RARE Numbers

RARE Price
(Ultragenyx Pharmaceutical stock price per share)
$45.57
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Biotechnology stocks
[?] Free Cash Flow Jitter 0%

Is Ultragenyx Pharmaceutical Stock on Sale?

Based on our analysis, we believe that you should not buy Ultragenyx Pharmaceutical right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy RARE Stock?

Does Ultragenyx Pharmaceutical have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.